Monitor the upcoming earnings call for guidance on full-year 2026, particularly regarding the integration of Clario and the impact of strategic collaborations with NVIDIA and SHL Medical on future growth.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 23 $466.52entry
- T+1 · 7mo ago +0.56%α −0.23% · $469.13
- T+5 · 7mo ago −0.06%α −1.53% · $466.26
- T+20 · 6mo ago −3.16%α −7.79% · $451.79
- T+60 · 4mo ago +14.14%α +9.22% · $532.48
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Thermo Fisher Scientific reported strong Q1 2026 results with revenue up 6% to $11.01B and GAAP EPS growing 11% to $4.43, driven by operational excellence and the Clario acquisition. The company raised its dividend by 10% and repurchased $3.0B in stock, signaling confidence in its financial position.
Key Financial Metrics
Key Facts
- Q1 2026 revenue grew 6% YoY to $11.01 billion
- GAAP diluted EPS grew 11% YoY to $4.43
- Adjusted EPS grew 6% YoY to $5.44
- Completed acquisition of Clario, a provider of endpoint data solutions
- Repurchased $3.0 billion of stock and increased dividend by 10%
Financial Impact
Revenue beat consensus by $145M, EPS beat by $1.19
Risk Factors
- Increased debt from the Clario acquisition could impact future financial flexibility
- Integrating Clario may pose operational challenges and cultural integration risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000097745-26-000086 |
| Document: tmo-20260423.htm | 0000097745-26-000086 |
| Document: 0000097745-26-000086-index-headers.html | 0000097745-26-000086 |
| Document: 0000097745-26-000086-index.html | 0000097745-26-000086 |
| Document: 0000097745-26-000086.txt | 0000097745-26-000086 |
| 8-K Data (Synthetic) | 0000097745-26-000086 |
Track record
21 reports on TMO
2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +29.04% at T+60 after the Jun 11, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $700.22 Now $691.33 −1.27% settles Feb 11
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $676.94 Now $691.33 +2.13% settles Feb 3
- Oct 30, 202617d ago 8-K Neutral 2/10 Entry $682.65 Now $691.33 +1.27% settles Jan 29
- Oct 28, 202619d ago 144 Neutral 2/10 Entry $709.18 Now $691.33 −2.52% settles Jan 27
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $694.02 Now $691.33 −0.39% settles Jan 19
- Oct 16, 20264w ago Institutional Cluster Neutral 3/10 Entry $690.00 Now $691.33 +0.19% settles Jan 13
- Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $608.54 Now $691.33 +13.60% settles Nov 27
- Aug 26, 202611w ago Insider Cluster Neutral 2/10 Entry $630.70 Now $691.33 +9.61% settles Nov 20
- Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $628.15 Now $691.33 +10.06% settles Nov 18
- Aug 18, 202613w ago Court Ruling Neutral 1/10 Entry $613.07 to $717.71 Now $691.33 +12.77% ▲ +17.07% +17.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers